SCHEMBL13497902

SCHEMBL13497902

CCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(Nc2nc(N[C@H](CO)C(C)C)nc3c2ncn3C(C)C)cc1Cl

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 14/20 0.72
CDK5R1 Q15078 14/20 0.72
CCNA2 P20248 12/20 0.72
CDK2 P24941 12/20 0.72
CCNA1 P78396 12/20 0.72
CDK1 P06493 7/20 0.72
KDM4E B2RXH2 3/20 0.72
CCNB2 O95067 3/20 0.72
ALDH1A1 P00352 3/20 0.72
CCNB1 P14635 3/20 0.72
CCNB3 Q8WWL7 3/20 0.72
CCNE2 O96020 2/20 0.72
INSR P06213 2/20 0.72
PRKACA P17612 2/20 0.72
PRKACG P22612 2/20 0.72
PRKACB P22694 2/20 0.72
CCNE1 P24864 2/20 0.72
MAPK3 P27361 2/20 0.72
NTRK1 P04629 1/20 0.72
NTRK2 Q16620 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13497968 0.95 CDK5 (0.73) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL14499679 0.93 CDK5 (0.72) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL13497904 0.91 CDK5 (0.67) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL14499686 0.90 CDK5 (0.68) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL13497946 0.90 CDK5 (0.68) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL14177997 0.84 CDK5 (0.68) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL13498146 0.84 CDK5 (0.87) CDK5CDK5R1CCNA2CDK2CCNA1
Purvalanol B SCHEMBL27951 0.84 CDK5 (1.00) CDK5CDK5R1CCNA2CDK2CCNA1
Purvalanol B SCHEMBL6932922 0.84 CDK5 (1.00) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL13497847 0.83 CDK5 (0.86) CDK5CDK5R1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048890-A1 CONJUGATED SMALL MOLECULES DISCOVERX CORPORATION 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048890-A1 CONJUGATED SMALL MOLECULES ERBB2, ALK, ACP1 CDK5 803/4885CDK5R1 1525/4885CCNA2 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.